The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

KOS AI Argus KOS AI, a Silicon Valley health technology firm, has developed a non-invasive glucose monitoring device t ...

Now at 32, he continues to live with the condition while endorsing advancements in diabetes care, particularly the Dexcom G7 glucose monitoring system ... is a type of wearable technology that ...

Abbott is already a big player in the wearable ... glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning ...

Each station is here to create baseline figures using the best scientific equipment ... Non-invasive glucose monitoring and cuff-less blood pressure monitoring are seemingly the wearable world’s next ...

Meanwhile, AI, remote monitoring and digital health ... for the patient and overburdened healthcare system. Wearable devices, such as continuous glucose monitors and smartwatches with ECG ...

This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose Monitoring System ... lasting and most accurate wearable, enhancing user convenience ...

including wearable biosensors, today announced compelling results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring (CGM) system. DUBLIN, Dec. 24 ...

Insulet Corporation ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its Board of Directors has appointed Ashley ...

To help you decide what to put on your wrist, we’ve rounded up the best smartwatches in 2025 for every kind of user. We have been testing smartwatches for years, pairing each new wearable with a ...

Biolinq received $100 million in a Series C funding round to bring its wearable for patients with diabetes to market, the ...